Evaluation of nucleic acid amplification technology (NAT) efficiency of hepatitis C virus (HCV) in pool screening systems.

被引：0
|
作者：
Habibuw, MR
Vrielink, H
Reesink, HW
Beld, M
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Virol, NL-1105 AZ Amsterdam, Netherlands
[2] Red Cross Blood Bank, Amsterdam, Netherlands
来源：
TRANSFUSION | 1998年 / 38卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S206
引用
收藏
页码：57S / 57S
页数：1
相关论文
共 50 条
  • [1] Experience in nucleic acid amplification testing (NAT) for hepatitis C (HCV) in Canada
    Sher, GD
    Zuber, ED
    Scalia, V
    TRANSFUSION, 2000, 40 (10) : 89S - 89S
  • [2] Viral Safety of Biologicals: Evaluation of Hepatitis C Virus (HCV) Nucleic Acid Amplification Test (NAT) Assay and Development of Concentration Method of HCV for Sensitive Detection by NAT
    Uchida, Eriko
    Yamaguchi, Teruhide
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (02): : 163 - 169
  • [3] Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening
    Dow, BC
    Munro, H
    Buchanan, I
    Ferguson, K
    Davidson, F
    Lycett, C
    Jarvis, M
    Cleland, A
    Petrik, J
    Lumley, S
    Maclean, A
    VOX SANGUINIS, 2004, 86 (01) : 15 - 20
  • [4] Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations
    Bamaga, Mohammad S.
    Bokhari, Fawzi F.
    Aboud, AbdulRahaman M.
    Al-Malki, Meshal
    Alenzi, Faris Q.
    SAUDI MEDICAL JOURNAL, 2006, 27 (06) : 781 - 787
  • [5] Comparison of two nucleic acid amplification technology systems for detection of human immunodeficiency virus,hepatitis B virus, and hepatitis C virus
    Coleman, Charl
    Lelie, Nico
    Rademeyer, Ronel
    van Drimmelen, Harry
    van den Berg, Karin
    Vermeulen, Marion
    TRANSFUSION, 2020, 60 (12) : 2929 - 2937
  • [6] Utilization of Kidneys from Deceased Donors with Positive Hepatitis C Nucleic Acid Amplification Testing (HCV NAT plus )
    King, K. L.
    Husain, S. A.
    Mohan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 421 - 421
  • [7] HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT)
    O'Riordan, J
    Williams, P
    Donnellan, J
    VOX SANGUINIS, 2005, 89 (04) : 266 - 266
  • [8] Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA
    Saldanha, J
    Lelie, N
    Heath, A
    VOX SANGUINIS, 1999, 76 (03) : 149 - 158
  • [9] Blood donor screening with nucleic acid amplification tests for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
    Kleinman, S.
    ISBT SCIENCE SERIES, VOL 3, NO 1, 2008, 3 (01): : 191 - 195
  • [10] Cost-effectiveness (CE) of screening donated blood with minipool nucleic acid testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV)
    Grima, DT
    Marshall, D
    Weinstein, M
    Wong, JB
    Kleinman, S
    AuBuchon, J
    VALUE IN HEALTH, 2002, 5 (06) : 446 - 446
12345